Overview

NICE no longer plans to develop guidance on Exploratory economic modelling of SARS-CoV-2 viral detection point of care tests and serology tests.

Diagnostics guidance DG10038 has been migrated to HealthTech guidance HTG10898.

Next review - If NICE is notified about this topic again then it will follow the NICE topic prioritisation process.